BEAM position history
The shares of Beam Therapeutics (BEAM) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 6,841,722 shares, $595M, 1.4% of portfolio
- 2021 Q4: 7,983,401 shares, $636M, 1.9% of portfolio, Add +16.7%
- 2022 Q1: 8,200,749 shares, $470M, 2.0% of portfolio, Add +2.7%
- 2022 Q2: 8,792,064 shares, $309M, 1.8% of portfolio, Add +7.2%
- 2022 Q3: 8,490,936 shares, $405M, 2.8% of portfolio, Reduce −3.4%
- 2022 Q4: 8,213,131 shares, $321M, 2.8% of portfolio, Reduce −3.3%
- 2023 Q1: 8,573,429 shares, $263M, 1.8% of portfolio, Add +4.4%
- 2023 Q2: 8,382,595 shares, $268M, 1.8% of portfolio, Reduce −2.2%
- 2023 Q3: 8,783,891 shares, $211M, 1.6% of portfolio, Add +4.8%
- 2023 Q4: 9,393,889 shares, $256M, 1.5% of portfolio, Add +6.9%
- 2024 Q1: 8,182,174 shares, $270M, 1.9% of portfolio, Reduce −12.9%
- 2024 Q2: 7,626,139 shares, $179M, 1.6% of portfolio, Reduce −6.8%
- 2024 Q3: 6,531,099 shares, $160M, 1.5% of portfolio, Reduce −14.4%
- 2024 Q4: 7,068,029 shares, $175M, 1.5% of portfolio, Add +8.2%
- 2025 Q1: 8,480,089 shares, $166M, 1.7% of portfolio, Add +20.0%
- 2025 Q2: 8,847,841 shares, $151M, 1.1% of portfolio, Add +4.3%
- 2025 Q3: 11,038,834 shares, $268M, 1.6% of portfolio, Add +24.8%
- 2025 Q4: 12,467,189 shares, $346M, 2.3% of portfolio, Add +12.9%
- 2026 Q1: 12,133,433 shares, $289M, 2.2% of portfolio, Reduce −2.7%
- 2026 Q2: 10,234,862 shares, $351M, 2.3% of portfolio, Reduce −15.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|